Volta Labs Launches with $20 Million in Series A
March 8, 2022
The bioautomation company emerges from stealth mode with investment led by Maverick Ventures and John Stuepelnagel (co-founder of Illumina) CAMBRIDGE, MA - Volta Labs, a bioautomation company developing solutions to streamline the upstream workflows in genomic sequencing, today announced it raised $20 million in a Series A funding round. The round was led by Maverick [...]
Tedia Announces Partnership with NewHold Enterprises
March 8, 2022
Tedia Announces Partnership with NewHold Enterprises Fairfield, OH & New York, NY, March 8, 2022 – Tedia Company, LLC (Tedia) today announced they have entered into a partnership with NewHold Enterprises, LLC (NewHold) through a strategic investment on March 4, 2022. Tedia is the largest manufacturer of OEM high-purity solvents in North America, selling its [...]
EKF Life Sciences and ABEC Partner for US Biomanufacturing Expansion
March 8, 2022
BETHLEHEM, Pa. -- ABEC, a leading global provider of engineered solutions and services for biotech manufacturing, today announced it will provide customized, large-scale bioprocess equipment, including a 14,500 liter total volume stainless steel fermenter and an 8,000 liter media preparation system to EKF Life Sciences, a division of EKF Diagnostics Holdings plc, which manufactures diagnostics enzymes [...]
LumaCyte Fueled for Growth, Names Top Life Sciences Industry Executives to Board
March 8, 2022
CHARLOTTESVILLE, Va. -- LumaCyte Corporation, a bioanalytical instrumentation leader in advanced label-free single-cell analytics, announced the successful completion of an A round financing that will allow the company to accelerate its global expansion efforts and service the increasing global demand of its flagship product, Radiance ®. LumaCyte will also use these funds to further expand the company’s [...]
March 8, 2022
OAKLAND, CA – Fabric Genomics, Inc., today announced that the Broad Institute of MIT and Harvard has selected the company to support the development and implementation of its clinical whole genome sequencing-based offerings. As part of the agreement, Fabric Genomics will provide the AI-based clinical decision support platform used to support the interpretation of clinical [...]
March 8, 2022
MOUNTAIN VIEW, Calif. -- DNAnexus, Inc., a leading provider of cloud-based biomedical data analysis software serving the life sciences community, today announced a $200 million financing round to accelerate the global adoption of its technology, translating the world’s complex multi-omics and clinical data into tangible insights and personalized treatments. The round was led by funds [...]
New, Innovative GC and GC-MS Product Portfolio Enables Greater Uptime and Efficiency
March 8, 2022
Updated GC and GC-MS portfolio from Thermo Fisher Scientific designed to deliver enhanced customer experience, easy adoption and simplified operations AUSTIN, Texas – Thermo Fisher Scientific Inc., the world leader in serving science, enables analytical testing laboratories across a variety of sectors, including food, environmental, industrial and pharma to now meet their ever-increasing efficiency and [...]
Nanalysis Scientific Corp. Announces Closing of Initial Equity Investment in Quad Systems
March 8, 2022
Calgary, Alberta -- (“Nanalysis” or the “Company”) in accordance with its press release dated January 18, 2022, the Company announces that it has funded the initial equity investment in Quad Systems AG (“Quad Systems”), acquiring 43% ownership and an option to purchase the remaining shares. “We are happy to have closed this initial portion of our [...]
GREINER BIO-ONE EXPANDS CELLDISC PORTFOLIO TO INCLUDE VERSIONS WITH CLOSED FILLING CAPS
March 7, 2022
To make your cell culture even safer, we have developed closed filling cups (-CF1 / -CF2) for the CELLdisc in close cooperation with our customers. Frickenhausen, March 2022 - Working in a highly regulated environment requires maximal security on sterility and hence a closed system for fluid transfer which excludes any opening of a cell [...]
March 7, 2022
NANJING/SUZHOU, China and COLOGNE, Germany and SINGAPORE -- Singleron Biotechnologies, a leading Chinese genomics company that develops groundbreaking single-cell multi-omics platform technologies and promotes their clinical translations, today announced the acquisition of Proteona Pte. Ltd., a Singapore-based precision medicine company offering single-cell biomarker discovery services to translational and clinical researchers across the globe. By acquiring [...]

